Personalized Medicine’s Bottleneck: Diagnostic Test Evidence and Reimbursement

Background: Personalized medicine is gradually emerging as a transformative field. Thus far, seven co-developed drug-diagnostic combinations have been approved and several dozen post-hoc drug-diagnostic combinations (diagnostic approved after the drug). However, barriers remain, particularly with re...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Joshua P., Felix, Abigail E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263971/
https://www.ncbi.nlm.nih.gov/pubmed/25563222
http://dx.doi.org/10.3390/jpm4020163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263971/
https://www.ncbi.nlm.nih.gov/pubmed/25563222
http://dx.doi.org/10.3390/jpm4020163

Ejemplares similares